Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P.
Delpont B, et al. Among authors: luscher c.
Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24.
Mov Disord. 2017.
PMID: 28737225